Showing results (1461-1470 of 1,500) with videos related to

Sort By:
Pageof 150
Blood|November 2, 2022
C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapseLi-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, et al.
The American Journal of Gastroenterology|December 7, 2016
Water Exchange Method Significantly Improves Adenoma Detection Rate: A Multicenter, Randomized Controlled TrialHui Jia, Yanglin Pan, Xuegang Guo, et al.
BMJ Open|October 23, 2018
Comparison of paclitaxel in combination with cisplatin (TP), carboplatin (TC) or fluorouracil (TF) concurrent with radiotherapy for patients with local advanced oesophageal squamous cell carcinoma: a three-arm phase III randomized trial (ESO-Shanghai 2)Dashan Ai, Yun Chen, Qi Liu, et al.
Iscience|July 1, 2024
GSK2334470 attenuates high salt-exacerbated rheumatoid arthritis progression by restoring Th17/Treg homeostasisQian Mo, Mansoor Bolideei, Shan-Jie Rong, et al.
Gut|March 20, 2025
Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trialXiaoyu Kang, Mingxing Xia, Jun Wang, et al.
The Journal of Clinical Investigation|January 10, 2023
UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancerJun Xiao, Fei Sun, Ya-Nan Wang, et al.
Digestive Diseases and Sciences|November 5, 2024
Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-AnalysisChristina J Sperna Weiland, Venkata S Akshintala, Anmol Singh, et al.
Military Medical Research|November 25, 2025
Effectiveness and cost-effectiveness of risk-adapted colorectal cancer screening: a randomized controlled trial and modeling analysisHong-Da Chen, Bin Lu, Ju-Fang Shi, et al.
Radiology|October 3, 2023
Comparison of Radiologists and Deep Learning for US Grading of Hepatic SteatosisPedro Vianna, Sara-Ivana Calce, Pamela Boustros, et al.
BMJ (Clinical Research Ed.)|April 20, 2022
Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trialZhihao Lu, Junye Wang, Yongqian Shu, et al.
Pageof 150